Newsroom
Sorted by: Latest
-
Resumen: Nuevo proyecto del JCDC: apoyo a la creación de cursos de cocina japonesa y envío de instructores a escuelas culinarias extranjeras
TOKIO--(BUSINESS WIRE)--Mientras siguen proliferando los restaurantes japoneses en el extranjero (según el último estudio, hay 187 000 locales, lo que supone un aumento del 20 % desde 2021), escasean los chefs con conocimientos y habilidades especializados en cocina japonesa, así como los instructores capaces de enseñar las técnicas de la cocina japonesa en las escuelas culinarias del extranjero. Para compensar esta carencia y seguir promoviendo la cocina, la cultura alimentaria y los ingredien...
-
Nouveau projet du JCDC : Contribution à l'ouverture de cours de cuisine japonaise et à l'envoi d'instructeurs dans des écoles culinaires à l'étranger
TOKYO--(BUSINESS WIRE)--Dans un contexte dans lequel les restaurants japonais à l'étranger continuent de se multiplier (selon la dernière enquête, il y a 187 000 établissements, soit une augmentation d'environ 20 % depuis 2021), il y a une pénurie de chefs ayant des connaissances et des compétences spécialisées dans la cuisine japonaise, ainsi que d'instructeurs capables d'enseigner les techniques de la cuisine japonaise dans les écoles culinaires à l'étranger. Afin de combler ce manque et de p...
-
UCTT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Ultra Clean Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Ultra Clean business and prospects, resulting in its stock trading at inflated prices....
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 25.03.2025 FCSG IE00BKPSPT20 1,375,002.00 USD 56,393,479.78 41.013 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 25.03.2025 FXGB LN IE00BD5HBR05 37,992.00 GBP 702,741.09 23.949 ...
-
DNA Payments Showcases New Payment Technologies at Retail Technology Show 2025, at ExCeL, London, 2nd and 3rd April
LONDON--(BUSINESS WIRE)--DNA Payments, a leading independent, full-service omnichannel payments provider, will be exhibiting at the Retail Technology Show, taking place at ExCeL, London on the 2nd and 3rd of April 2025. This premier event, a crucial hub for innovation in the retail sector, will provide DNA Payments and their partners, sunday and Lolly, with a platform to demonstrate their cutting-edge payment solutions and connect with industry leaders. With over 400 exhibitors and more than 15...
-
Viseon Inc. Unveils First Use of Innovative Hubble™ AV System in Neurosurgery
IRVINE, Calif.--(BUSINESS WIRE)--Viseon is innovating new neuro-cranial products, Hubble AV, for therapeutic visualization and integration into evolving enabling technologies....
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 25.03.2025 FTFX IE00BD5HBQ97 63,402.00 USD 1,545,529.30 24.377 ...
-
Mannatech Reports Fourth Quarter 2024 Financial Results
FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter of 2024. Quarter End Results Fourth quarter net sales for 2024 were $29.0 million, a decrease of $3.7 million, or 11.3%, as compared to $32.7 million in the fourth quarter of 2023. During the fourth quarter, the company's net sales declined 9.2% on a Constant dollar basi...
-
ImmunityBio to Host Investor Day
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, invites current and prospective investors to its Investor Day program to be held on Tuesday, April 15, 2025, at 10:00 am PDT. The program will include an in-depth update on the company’s business operations and recent R&D advancements. Key timelines for catalysts of product candidates will be presented, along with a discussion of ongoing clinical trials. “ImmunityBio commenced 2025 with...